New data indicate a sustained and substantial overall and disease-specific survival benefit associated with androgen deprivation therapy (ADT) plus radiation therapy among patients with locally advanced prostate cancer. John Schieszer reports in today’s Medical Minute that the combination treatment was associated with a minimal increase in late-treatment toxicity.

Topics:

Androgen-deprivation Therapy Prostate Cancer